“Since returning from the UK the AGITG has been a major part of my professional life. As a gastrointestinal Medical Oncologist, the expertise and advice of colleagues with similar interests has been invaluable in the progress of my career as a GI clinician and researcher. Subsequently I was given the opportunity to join the board and SAC and be part of the group’s growth and contribute to the ongoing research program.
The AGITG has led trials that have made significant contributions to the improvement in care for patients with GI cancers and I have been proud to be part of this team. My main task now having taken on the role of Chair of the board and SAC is to try to continue the fantastic work achieved thus far and hopefully build further with the collaboration of our many members who give up significant time in their busy lives to be part of the group’s research program”
Professor Tim Price is the current Chair of the Board of the AGITG. He is also presently serving as the Chairperson of the AGITG Scientific Advisory Committee. Before becoming the AGITG Chair in 2004, he held the position of Director and Company Secretary.
His major clinical interest is the treatment of patients with gastro-intestinal cancer. Professor Price trained in Medical Oncology at the Royal Adelaide Hospital. He developed his expertise in treating GI Cancer during a Gastrointestinal Fellowship at Royal Marsden Hospital and Institute of Cancer Research in London.
Following his fellowship he returned to Australia and was appointed to Consultant Medical Oncologist at the Queen Elizabeth Hospital in Adelaide. The hospital has since appointed him as Head of Clinical Oncology Research and Chair of the combined Haematology and Medical Oncology Unit.
Professor Price is a member of the National Panel of Examiners for the Royal College of Physicians. He is actively involved in student teaching and postgraduate education. He is a professor at the University of Adelaide and an Honorary Associate with NHMRC Clinical Trials Centre at Sydney Medical School.
He is currently a Colorectal Cancer Stream leader for the South Australian Health and Medical Research Institute. Professor Price has translational and research collaborations with the Bazil Hetzel Institute, working to ensure that basic research findings are tested in clinical settings and that proven treatments and interventions become standard medical practice.